Table 5.
Susceptibility of Acinetobacter and Pseudomonas pathogens to antibiotics.
| Antibiotics | 2016 ( n = 4) | 2017 ( n = 4) | 2018 ( n = 6) | 2019 ( n = 6) | Total ( n = 20) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | n | % | |
| Cefazolin | 1 | 25.0 | 0 | / | 0 | / | 0 | / | 1 | 5.0 |
| Ceftazidime | 0 | / | 0 | / | 0 | / | 0 | / | 0 | / |
| Cefoperazone | 0 | / | 0 | / | 0 | / | 0 | / | 0 | / |
| Cefodizime | 2 | 50.0 | 0 | / | 0 | / | 0 | / | 2 | 10.0 |
| Gentamicin | 2 | 50.0 | 0 | / | 0 | / | 0 | / | 2 | 10.0 |
| Ciprofloxacin | 0 | / | 0 | / | 0 | / | 1 | 16.7 | 1 | 5.0 |
| Levofloxacin | 0 | / | 0 | / | 2 | 33.3 | 0 | / | 2 | 10.0 |
| Imipenem | 0 | / | 2 | 50.0 | 3 | 50.0 | 3 | 50.0 | 8 | 40.0 |
| Tetracycline | 0 | / | 0 | / | 3 | 50.0 | 3 | 50.0 | 6 | 30.0 |
| Chloramphenicol | 3 | 75.0 | 0 | / | 0 | / | 0 | / | 3 | 15.0 |
| Piperacillin | 0 | / | 0 | / | 1 | 16.7 | 0 | / | 1 | 5.0 |
| Vancomycin | 4 | 100.0 | 4 | 100.0 | 6 | 100.0 | 6 | 100.0 | 20 | 100.0 |
| Clindamycin | 0 | / | 0 | / | 0 | / | 0 | / | 0 | / |
| Amikacin | 0 | / | 0 | / | 0 | / | 0 | / | 0 | / |
| Meropenem | 4 | 100.0 | 3 | 75.0 | 4 | 66.7 | 4 | 66.7 | 15 | 75.0 |
| Rifampicin | 4 | 100.0 | 4 | 100.0 | 6 | 100.0 | 6 | 100.0 | 20 | 100.0 |